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Although the functional parameters of microRNAs (miRNAs) have
been explored in some depth, the roles of these molecules in viral
infections remainelusive.Herewereport ageneralmethodforglobal
analysis of miRNA function that compares the signiﬁcance of both
overexpressing and inhibiting each mouse miRNA on the growth
properties of different viruses. Our comparative analysis of repre-
sentativesofall threeherpesvirus subfamilies identiﬁedhostmiRNAs
with broad anti- and proviral properties which extend to a single-
stranded RNA virus. Speciﬁcally, we demonstrate the broad antiviral
capacity of miR-199a-3p and illustrate that this individual host-
encoded miRNA regulates multiple pathways required and/or acti-
vated by viruses, including PI3K/AKT and ERK/MAPK signaling,
oxidative stress signaling, and prostaglandin synthesis. Global miRNA
expression analysis further demonstrated that the miR-199a/miR-214
cluster is down-regulated inbothmurine andhuman cytomegalovirus
infection and manifests similar antiviral properties in mouse and
human cells. Overall, we report a general strategy for examining the
contributions of individual host miRNAs in viral infection and provide
evidence that these molecules confer broad inhibitory potential
against multiple viruses.
RNAi | herpesvirus | RNA virus | RNA processing | phosphatidylinositol-3-
kinase-Akt signalling
Since the discovery of the ﬁrst microRNA (miRNA) in Caeno-rhabditis elegans, research in diverse organisms has illuminated
the role of this class of small RNA in a wide range of cellular pro-
cesses (reviewed in ref. 1). MicroRNAsmodulate the expression of
speciﬁc genes by guiding the RNA-induced silencing complex
(RISC) to complementary sites within messenger RNAs (mRNAs)
(2). This generally serves to down-regulate target genes at speciﬁc
times, in concert with other regulatory mechanisms in the cell
(reviewed in ref. 3). Functional analysis of individual miRNAs
suggests diversity in the timing and mechanisms by which they
regulate cellular events. For example, some miRNAs promote
cellular proliferation, whereas others promote apoptosis (depend-
ingonwhich genes are targeted).Consequently, the expression level
of a given miRNA within a cell is expected to be under tight regu-
latory control, and mechanisms for achieving this control continue
to emerge (reviewed in ref. 4).
Viruses require host-cell processes for their survival and have
evolved mechanisms for modifying cellular conditions toward an
environment conducive to replication while evading recognition and
destruction by the host.Herpesviruses are one of the oldest andmost
successful viral families in this regard.Theyhave coevolvedwith their
hosts for hundreds ofmillions of years and infect nearly all vertebrate
species studied and at least one invertebrate (5). Human cytomeg-
alovirus (HCMV), a member of the β-herpesvirus subfamily that in-
fects a large portion of the world’s population (50–90%), is a leading
causeof congenital infection (~1%of livebirths) andamajor causeof
morbidity in immunocompromised patients. Although mouse and
human cytomegaloviruses have diverged over ~80 million years, the
pathophysiology of murine CMV (MCMV) inmice is similar to that
of HCMV in humans, and the lytic infections result in activation and
manipulation of common host-cell signaling cascades (6).
Because miRNAs regulate many aspects of cellular physiology,
their expression levels could impact the infection process. It might
be expected, therefore, that host miRNA expression is subject to
regulation upon infection, by either viral or host factors. Indeed, we
and others have previously identiﬁed host miRNAs that are down-
regulated upon infection by cytomegaloviruses (in some cases
within 4 h postinfection) and have demonstrated that these miR-
NAs exert antiviral propertieswhenoverexpressed (7, 8).However,
to date, there has been no overlap between results reported with
MCMV and HCMV, nor has there been any context with which to
interpret the signiﬁcance of the effect of overexpressing a given
miRNA in relation to any other miRNA in the cell. Similarly,
various groups have identiﬁed mammalian miRNAs that are reg-
ulated or implicated in diverse viral infections, but the majority of
these studies are generally founded on expression proﬁling or
miRNA target predictions, (reviewed in ref. 9; ref. 10). There is rel-
atively little investigation to date on the functional impact of
miRNAs in different infections.
We postulate that speciﬁc subsets of host miRNAs are impor-
tant in controlling the infection process and might be subject to
regulation by host and/or viral factors. Although the kinetic
parameters ofmiRNA action are not well-known (e.g., how quickly
and reversibly they can modulate a gene or pathway), we expect
that viruses with slower replication kinetics (>24 h) might be
particularly sensitive to (and exploitive of) changes in host miRNA
expression levels. Here we report a combined agonist–antagonist
miRNA screening approach that is designed to obtain functional
information about mouse miRNAs that impact the lytic phase of
herpesviral infections. We further test the breadth of observed
antiviral miRNA properties in human cells and against an evolu-
tionarily unrelated RNA virus. Our functional and expression
analyses demonstrate that host miRNAs are a tunable and im-
portant component of herpesviral infection and provide evidence
that these molecules have broad antiviral properties in mouse and
human cells against both DNA and RNA viruses.
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Results
Agonist–Antagonist MicroRNA Screen. The combined agonist–
antagonist miRNA screening protocol involves analyzing the im-
pact on viral growth of parallel overexpression and inhibition
of miRNAs using synthetic mimics or inhibitors (Fig. 1A). The
miRNAmimics are synthetic RNAduplexes designed to efﬁciently
load a functional mature miRNA strand into RISC. The miRNA
inhibitors are single-stranded oligonucleotides that are chemically
modiﬁed for enhanced binding to mature miRNAs and resistance
to nucleolytic cleavage (11). Transfection conditions were opti-
mized to obtain the highest level of transfection efﬁciency without
inducing toxicity (SI Methods and Fig. S1). Viral growth is moni-
tored using viruses that encode green ﬂuorescent protein (GFP)
reporters. Screening is conducted in a murine ﬁbroblast cell line
(NIH 3T3) that supports replication of representatives of all three
herpesviral families (α, β, γ): herpes simplex virus 1 (HSV-1),
MCMV, and murine gamma herpesvirus 68 (MHV-68) (Fig. 1B).
Cells are infected at a low multiplicity of infection (MOI; 0.2–0.5),
in order that theﬂuorescent signal detected by ~60–70 h is based on
multiple rounds of replication. Therefore, the impact of a miRNA
on any stage of the replication cycle is detectable.An assumption in
this screening approach is that general miRNA transfection alone
does not itself impact viral replication. This is conﬁrmed by control
transfections withC. elegansmiRNAmimics or inhibitors as well as
a “RISC-free” small interferingRNA(siRNA), which is chemically
modiﬁed tobe takenupby cells but not incorporated into theRISC:
These reagents do not cause a signiﬁcant change in theGFP signal,
compared with >50% knockdown with siRNAs directed against
GFP (Fig. S1). Controls are included in each plate to normalize
plate-to-plate variation in ﬂuorescent intensity (SI Methods and
Fig. S2), and cell-viability assays are performed in parallel to
remove from further analysis those reagents that are toxic. In the
library analyzed here, a total of 338 pairs of mimics and inhibitors
were initially screened (representing 286 unique miRNAs).
Twenty-six members of the miRNA mimic library were excluded
due to toxicity (SI Methods).
Rank Product Statistical Analysis. Mouse miRNAs that negatively
impact viral growth are deﬁned in this assay as those that decrease
ﬂuorescence in the mimic library and increase ﬂuorescence in the
inhibitor library. A common metric for qualifying such “hits” is to
accept those mimics or inhibitors that cause a clear difference in
ﬂuorescence signal compared with the negative controls (for ex-
ample, 2 SDs outside the mean of negative controls), reviewed in
ref. 12. However, analysis of the mimic and inhibitor data suggests
a stark difference in distributions andmagnitude of effects of these
reagents: The miRNA mimics generally have a much larger effect
on the virus, whereas inhibitor results are more subtle (Fig. S2).
Although off-targets may be observed with a given mimic in some
circumstances, we anticipate that comparison of both mimic and
inhibitor increases the chances that observed effects on viral
growth are speciﬁc (and not idiosyncratic to a particular reagent).
The lesser number of inhibitor hits can be partly attributed to the
fact that inhibitors only act on expressed endogenous miRNAs and
not all miRNAs will be expressed in this cell type.
We therefore opted to identify hits using a robust, nonpa-
rametric statistical method that is based on signal ranking and
replication between experiments (explained further in SIMethods).
“Hits” are deﬁned asmimics or inhibitors that result in a high or low
ﬂuorescent signal in comparison with the rest of the library, and
statistical weight is based on replication between experiments (13).
Using this method, “antiviral” miRNAs are deﬁned as those that
consistently result in a low ﬂuorescent signal in the mimic library
(i.e., overexpression inhibits the quantity of GFP-tagged virus) and
a high ﬂuorescent signal in the inhibitor library (due to loss of
miRNA-repressor function). Similarly, “proviral” miRNAs are in-
dicated by a highﬂuorescent signal when overexpressed (asmimics)
or low ﬂuorescent signal when inhibited. The impact of these
reagents on GFP signal can be visualized as a volcano plot in Fig.
2A, which shows a clear correlation between the signiﬁcance of the
rank and the fold change induced by the mimic or inhibitor. Most
importantly, the rank-based P values have a more symmetrical
distribution, even though the fold-change distribution is quite dif-
ferent, allowing an unbiased selection of signiﬁcant results from
both mimic and inhibitor experiments.
MicroRNAs with Common Anti- or Proviral Properties in Multiple
Viruses. Those miRNAs with signiﬁcant (but opposite) effects on
viral growth in mimic and inhibitor datasets are shown in Fig. 2B.
Excluding miRNAs displaying toxicity, a total of 312 mimics and
inhibitors were analyzed. Using the combined datasets for all three
viruses, we identiﬁed four high-conﬁdence antiviral miRNAs: miR-
24, miR-103, miR-199a-3p, and miR-214 (decreased ﬂuorescence
in the mimic library, increased ﬂuorescence in the inhibitor library)
and three high-conﬁdence proviral miRNAs: miR-30b, miR-30d,
andmiR-93 (increased ﬂuorescence in themimic library, decreased
ﬂuorescence in the inhibitor library). We then conﬁrmed the
screening results in three independent experiments. Five of the
miRNAs (miR-24,miR-103,miR-199a-3p,miR-30b, andmiR-30d)
displayed similar anti- or proviral properties in all three herpesvi-
ruses, whereas the other two (miR-93 and miR-214) showed mixed
effects (Fig. 3A). These miRNAs are perfectly conserved between
mouse and human and we therefore extended the analysis to the
human CMV virus. As shown in Fig. 3B, the same anti- or proviral
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Fig. 1. Combined agonist–antagonist miRNA screening. (A) Overview of
screening protocol: MicroRNA mimics or inhibitors were reverse-transfected
into NIH 3T3 cells (six technical replicates) and incubated for 60 h before cell-
viability analysis (n = 3) or infection with GFP virus (n = 3). (B) Fluorescent
growth curve of GFP-reporter viruses in NIH 3T3 cells; Y1 axis shows values
forMCMV andMHV-68 and Y2 shows values for HSV-1; error bars depict SD of
three technical replicates.
Santhakumar et al. PNAS | August 3, 2010 | vol. 107 | no. 31 | 13831
M
ED
IC
A
L
SC
IE
N
CE
S
properties of these miRNAs are observed in human and murine
CMV infection (with the exception of miR-93).
Because the MCMV, MHV-68, HSV-1, and HCMV genomes
share little sequence similarity, the impact of thesemiRNAson viral
growth is probablydue to regulationofhost genes, rather thandirect
interactions with viral elements. To gain perspective on the breadth
of these effects, we also examined Semliki Forest virus (SFV), an
arthropod-borne, positive-strand RNA virus of the Togaviridae
family that is evolutionarily unrelated to the herpesviruses. SFV
replicates in the cytoplasmof infected cells such asNIH3T3, andwe
have previously used a Renilla luciferase (RLuc)-expressing SFV to
analyze vertebrate immune responses (14, 15). Cells were trans-
fected with mimics or inhibitors and RLuc signal was measured 8 h
postinfection with SFV (MOI = 0.5). Of the seven miRNAs tested
in Fig. 3A, four showed anti- or proviral properties based on over-
expression, with miR-199a-3p and miR-214 mimics resulting in
decreased luciferase signal and miR-30 mimics resulting in in-
creased luciferase signal (as observed with the herpesviruses).
To conﬁrm that the effects observed using the reporter virus are
a reliable measure of the quantity of infectious virus, experiments
were repeated using the wild-type MCMV virus and quantiﬁed
with standard plaque assays. Under the same transfection con-
ditions as the screen, the mimics resulted in a ca. 10-fold effect on
the quantity of infectious virus whereas inhibitors resulted in ca.
2- to 5-fold effects (Fig. S3). Growth-curve analysis further
demonstrated a 10- to 100-fold decrease in infectious virus based
on miR-199a-3p and miR-214 mimics and a 10-fold increase in
quantity of virus with the miR-30dmimic at 3 d postinfection (Fig.
3D). Plaque assays with MHV-68 and HSV-1 further conﬁrm
reporter results, with the miR-199a-3p mimic resulting in >10-
fold reductions in infectious virus (in both cases) and the miR-30
mimic resulting in 5- to 10-fold increases (Fig. S3).
It is important to note that this analysis is limited to miRNAs
expressed in ﬁbroblasts whose overexpression and inhibition
cause the most signiﬁcant effects on viral growth in three distant
herpesviruses. Therefore, a number of real (and perhaps more
subtle) functions of miRNAs during the lytic infections are likely
to have been missed. In addition, some miRNAs displayed
a signiﬁcant effect on one virus but not on others (e.g., miR-29b
is antiviral in HSV-1 and miR-378 is proviral in MCMV; Fig.
2B). These may represent miRNAs that interact with speciﬁc
viral elements or that regulate host genes required by one virus
but not the others; this requires further investigation. A full list
of rank product results is provided in Dataset S1.
miR-199a/214 Cluster Is Down-Regulated upon Murine and Human
Cytomegalovirus Infection. The aforementioned experiments dem-
onstrate that the concentration of speciﬁc host miRNAs within
a cell can have a signiﬁcant impact on viral growth capacity. Al-
though the manipulation of such miRNAs could potentially be
exploited in a therapeutic context, we expect that those miRNAs
most relevant to the infection process might be naturally up- or
down-regulated upon infection, either as a host response to viral
infection or as a viral strategy to manipulate the host. To determine
whether the miRNAs identiﬁed as functionally important in the
screen are also regulated upon infection, globalmiRNAmicroarray
analysis was conducted with both the murine and human CMV
viruses in murine and human ﬁbroblasts. Although an ideal com-
parison would involve all three herpesviral subfamilies, we focused
on the cytomegaloviruses because the ﬁbroblast cell type used in
the screening is a cell type naturally infected by these viruses in vivo.
Overall, 47 and 34 probes (out of a total of 648 combined mouse
and human probes proﬁled) displayed a ≥1.5-fold change in re-
sponse to MCMV or HCMV, respectively (measured 24 and 48 h
postinfection, respectively), based on P value < 0.05, corrected for
false discovery rate (FDR) (SIMethods and Fig. S4). FourmiRNAs
were identiﬁed as differentially expressed in both infections: miR-
29b*, miR-322, miR-503, and miR-199a-5p (Fig. 4A and Dataset
S2). This demonstrates overlap in the host miRNAs that are altered
in murine and human infection. In particular, all three members of
the miR-199a/214 cluster (miR-199a-3p, miR-199a-5p, and miR-
214) were signiﬁcantly down-regulated in eitherMCMVorHCMV
(or both) according to array analysis (Fig. 4A). Northern blot
analysis conﬁrmed down-regulation of the entire cluster in both
mouse and human CMV infection (Fig. 4B). This is in contrast to
the individual changes previously reported for each virus (e.g., miR-
100 is down-regulated upon HCMV infection and miR-27 is down-
regulated upon MCMV infection), which we also observed under
these conditions (Fig. 4). None of the other miRNAs examined in
Fig. 3 were found to be regulated under these conditions by the
cytomegaloviruses (Dataset S2). Regulation might, however, occur
in other cell types or at time points not analyzed here. The array
results reported here overlap with a previous study that identiﬁed
23 miRNAs that were down-regulated upon HCMV infection (11
of the 23 previously reported are conﬁrmed here), although a direct
comparison cannot be made due to different probe sets and cov-
erage of the microarray platforms (7).
miR-199a-3p Regulation of Host Signaling Networks. Because miR-
199a-3p had the largest antiviral effect on MCMV (Fig. 3D)
and was expressed at a high level in both murine and human cells
(Fig. 4), we focus here on genes regulated by this miRNA. Pre-
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Fig. 2. Rank product results. (A) Volcano plot of rank product P values
based on decreased ﬂuorescent signals in the mimic library and increased
ﬂuorescent signals in the inhibitor library. The x axis shows log-2 ﬂuorescent
changes for mimic or inhibitor (relative to negative controls) and the y axis
shows the corresponding multiple-testing corrected P value. For graphing
purposes, we curtailed the minimum P value at 0.00001. (B) Heat map
showing the mean rank in each library (based on 1→312, the number of
mimics and inhibitors screened excluding those that were toxic). Only miR-
NAs that displayed signiﬁcant (and opposite) effects in mimic and inhibitor
libraries are shown. Hits speciﬁc to an individual virus are denoted according
to 1: MCMV and 2: HSV-1. ***, miRNAs that were identiﬁed to be signiﬁcant
when combining datasets for all three viruses.
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vious studies have demonstrated that miRNAs cause a level of
degradation in their targets that can be interrogated by micro-
array analysis and is often comparable to the extent of change
occurring at the protein level (16, 17). Messenger RNA expres-
sion levels were examined in cells transfected with the miR-199a-
3p mimic versus inhibitor (under the same transfection conditions
used in screening; SI Methods). To assess whether differences in
gene expression between these samples could be explained by
direct targeting of miR-199a-3p, an unbiased computational
analysis was performed using Sylamer (18). Brieﬂy, Sylamer tests
for miRNA-speciﬁc effects by searching sorted gene lists for en-
richment or depletion of words complementary to miRNA seeds
[the ﬁrst 1–7 or 2–8 nucleotides of a miRNA that largely dictate
target interactions (3)]. Genes were sorted based on decreased
expression in mimic samples compared with inhibitor samples
(left to right, Fig. 5A). The only seed-matching words that dis-
played a signiﬁcant enrichment in the down-regulated genes
corresponded to miR-199a-3p (Fig. 5A); this is also the case when
examining mimic or inhibitor datasets individually, compared
with a negative control, RISC-free siRNA (Fig. S5). Pathway
analysis of genes down-regulated in cells transfected with mimic
compared with inhibitor (202 in total, based on 1.4-fold cutoff and
FDR P < 0.05) shows enrichment for pathways normally up-
regulated upon infection (19). Speciﬁcally, the top 10 signiﬁcantly
enriched pathways include: ERK/MAPK signaling, PI3K/AKT
signaling, prostaglandin synthesis, oxidative stress signaling, and
viral entry (Table S1). TargetScan (20) identiﬁes 53 of the 202
down-regulated genes as containing seed-matching sites for miR-
199a-3p in mouse, and 31 of these also contain seed sites in hu-
man (Dataset S3). To account for targets that might be regulated
at a level below 1.4-fold, we also list in Dataset S3 genes that are
down-regulated in the mimic versus inhibitor samples based on
the highest conﬁdence (lowest P values), rather than fold changes.
From these lists, genes regulated by miR-199a-3p that are known
to be relevant to CMV infection are depicted in Fig. 5B. These
include an integrin, ITGA6, which has been shown to be impor-
tant for human CMV entry (21); MAP2K1/2 (alias MEK1/2) and
PIK3CB, key intermediates in signaling pathways required for
viral replication and cell survival (22, 23); and PSTG2 (alias
COX2), an enzyme involved in prostaglandin synthesis that is
required for effective viral replication and cell-to-cell spread in
HCMV (24, 25). All of the regulated genes in Fig. 5B are down-
regulated by miR-199a-3p mimic and up-regulated by miR-199a-
3p inhibitor compared with the negative transfection control, with
the exception of ITGA6, which is only up-regulated by the in-
hibitor (Dataset S3).
Discussion
Small RNAs are involved inmany aspects of virus–host interactions
from plants to vertebrates, but despite considerable progress in this
ﬁeld a more global view of the miRNA–virus interplay is often
missing. Previous reports have shown that disrupting the miRNA
machinery can have variable effects on mammalian viruses. For
example, some viruses have higher titers in the absence of the
miRNA-processing enzyme Dicer, whereas other viruses show the
opposite trend (26). We anticipate that interpretation of such
experiments (reﬂecting the net effect of all miRNAs in the cell) is
complicated by the fact that host miRNAs have diverse (and op-
posing) impacts on viruses and, in addition, some viruses encode
their own miRNAs (9, 27). Here we describe a general method to
study the individual contributions of cellular miRNAs to viral
growth and test the hypothesis that speciﬁc miRNA subsets are
involved in (and consequential to) lytic herpesviral infections.
Comparing functional data with miRNA expression analysis, we
ﬁnd that those miRNAs that exhibit the most signiﬁcant antiviral
properties (miR-199a-3p and miR-214; Figs. 2 and 3) are among
a small subset of miRNAs down-regulated in both murine and hu-
man cytomegalovirus infections (Fig. 4). This demonstrates overlap
in the function and regulation of host miRNAs in a murine and
human virus and supports the idea that interrogation of miRNA
function in animal models is relevant to human disease. A paper
published recently reported miR-132 as a miRNA up-regulated in
Fig. 3. Validation of anti- and proviral
properties of miRNAs in mouse and human
cells. (A) Normalized ﬂuorescent values of
NIH 3T3 cells infected with MCMV [MOI =
0.2, 70 h postinfection (hpi)], MHV-68 (MOI =
0.5, 57 hpi), and HSV-1 (MOI = 0.5, 57 hpi). (B)
Normalized ﬂuorescent values ofMRC-5 cells
infected with HCMV (MOI = 0.5, 75 hpi). (C)
Normalized luciferase values of NIH 3T3 cells
infected with SFV (MOI = 0.5, 8 hpi). Cells
were transfected with 25 nM miRNA mimics
or inhibitors 60 h before infection; values for
mimics are shown in gray and inhibitors are
in etched gray. NC, negative control; PC,
positive transfection control. Data are nor-
malized to values obtained with C. elegans
mimic and inhibitor. (D) MCMV growth
curve in NIH 3T3 cells transfected with 25 nM
controls compared with miR-199a-3p, miR-
214, and miR-30d mimics; cells were infected
at an MOI of 0.01; PFU, plaque-forming
units. In all experiments, n = 3 and error bars
indicate SD.
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Kaposi’s sarcoma-associated herpesvirus infection that facilitates
viral replication and regulates antiviral innate immunity (28). This
further supports the concept that some mammalian hosts and
viruses might have evolved mechanisms to regulate individual
miRNAs (or speciﬁc subsets) upon infection, rather than targeting
the global miRNA machinery. Further work in other infection sys-
tems and cell types is required for a more global perspective of the
antiviralmiRNAs identiﬁed here, as well as formiR-132, which was
excluded from our analysis due to nonspeciﬁc effects in the mimic
library (SI Methods).
We previously reported rapid down-regulation of miR-27a and
miR-27b in MCMV infection and speculated that this regulation
might reﬂect antiviral functions of these miRNAs (8). Neither
miR-27a nor miR-27b is among the most signiﬁcant antiviral
miRNAs identiﬁed here. However, our analysis is limited to
those miRNAs that display the most dramatic (and opposite)
effects on viral growth when overexpressed and inhibited in
ﬁbroblasts. Although this allows for high conﬁdence in the hits
identiﬁed, it may miss more subtle, but real, effects of other
miRNAs and will be cell-type-speciﬁc. An underlying assumption
is also that overexpression of a miRNA increases the extent to
which it represses its targets; this depends on the concentrations
of miRNAs and targets, which will be variable in different cells.
Further understanding of miRNA biology is required to shed
light on the generality of this assumption. Although miR-27a and
miR-27b are not scored as signiﬁcant in the mimic libraries
(according to rank product analysis), they are among the most
signiﬁcant antiviral miRNAs when examining the combined in-
hibitor datasets for all three viruses, along with miR-24 and miR-
23b (Dataset S1), with which they are coregulated.
We focus here on miRNAs with common properties in multiple
herpesviral infections; however, there are notable differences in
the screening results with different viruses (for example, miR-378
is proviral in MCMV but not the other infections; Fig. 2B).
Viruses can evolve miRNA binding sites in their genomes (29),
and it is possible that differences observed here are related to
sequence-speciﬁc miRNA interactions with viral elements. Given
the expected frequency of miRNA target sites in a ~200,000-base-
pair herpesviral genome (on average, a 7-mer seed site will occur
every ~16,384 nt), investigations in this area will require extensive
biochemical validation.
To date, the therapeutic capacity of miRNA manipulation in
viral infection has focused primarily on blocking interactions be-
tween a host miRNA and a viral sequence (for example, miRNA-
122/HCV) (29, 30). Here we ﬁnd that miR-199a-3p leads to de-
creased viral growth in all three herpesviral subfamilies as well as
an unrelated positive-strand RNA virus. Although we cannot elimi-
nate the possibility that the antiviral properties are at least partly
Fig. 4. Changes in miRNA expression upon MCMV or HCMV infection. (A)
Heat map displaying differential expression of mouse and human miRNAs in
MCMV (NIH 3T3 cells, MOI = 3; 24 hpi) or HCMV (MRC-5 cells, MOI = 3; 48 hpi).
Color scale is based on log-2 changes in expression; probes identiﬁed as sig-
niﬁcant in each dataset are bracketed (left, MCMV; right, HCMV), with overlap
depicted. FC, fold change. (B). Northern blot analysis of total RNA isolated
frommouseﬁbroblast NIH 3T3 cells infected withMCMV atMOI = 3 (24 hpi) or
human ﬁbroblast MRC-5 cells infected with HCMV at MOI = 3 (48 hpi). Dashed
lines indicate a gap between lanes that was removed in making the image.
Fig. 5. Cellular networks modulated by
miR-199a-3p. (A) Plot of the signiﬁcance
of enrichment of all 7-mer words com-
plementary to knownmousemiRNA seed
regions in the mRNA array dataset, com-
paring mimic against inhibitor results.
The x axis represents all of the geneswith
an annotated 3′UTR sequence, sorted
starting from the most down-regulated
by the miR-199a-3p mimic (equivalent to
the most up-regulated by the inhibitor).
The y axis represents the −log10 trans-
formed P values, with positive values
denoting enrichment and negative val-
ues denoting depletion. Each gray line
represents a single 7-mer, tested for en-
richment and depletion at every 250
genes. Two seed-matching 7-mers for
miR-199a-3p, 7-mer(1A) = CTACTGA and
7-mer(2) = ACTACTG, are highlighted in
gold and red, respectively. Horizontal dotted lines represent Bonferroni-corrected P value signiﬁcance thresholds of 0.01. (B) Pathways regulated by miR-199a-3p
that are known to play a role in CMV infection. Selected genes down-regulated by miR-199a-3p are shown in blue circles (and are shaded if they also represent
a predicted target); human alias gene names are used.
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based on interactions with viral elements [as suggested in HCV
(31)], we identify several host pathways regulated by this miRNA
that are activated and required by multiple viruses. Speciﬁcally,
ERK/MAPK signaling, prostaglandin synthesis, oxidative stress
signaling, and PI3K/AKT signaling are all down-regulated by miR-
199a-3p (Fig. 5 and Table S1). The regulation of these pathways by
miR-199a-3p is consistent with previous (although diverse) reports
on miR-199a-3p, a stress-inducible miRNA up-regulated during
cardiac hypertrophy (32) that is also reported to target MET (33),
a transmembrane tyrosine kinase receptor associated with invasive
growth of tumors, and COX2 (34), an enzyme involved in prosta-
glandin synthesis. Our ﬁndings suggest links between this miRNA
and viral infection. Greater understanding of the role of miR-199a-
3p in normal and disease biologywill shed light on the best strategies
for exploiting its antiviral properties. It is notable that the other
miRNA with which it is coregulated, miR-214, is among the four
miRNAs identiﬁed here as broadly antiviral, (Figs. 2 and 3) andmay
function in concert with miR-199a-3p.
Given the large number of potential targets of any given
miRNA [on average, in the hundreds (35)], and in particular those
described in this study, it may not be that one speciﬁc target (or
even a handful of targets) sufﬁciently explains a miRNA-related
phenotype. We anticipate that understanding miRNA function
may require a “whole is greater than the sum of the parts” ap-
proach (involving multiple targets), which might also hold true in
developing more effective antiviral therapeutics.
Methods
For a full description of the methods used here, see SI Methods. The miRNA
mimic and inhibitor libraries are based on miRBase 8.2. The engineered re-
porter viruses have been described elsewhere (14, 36–39). MicroRNA micro-
arrays are based on Exiqon miCURY probe set version 8.1. Pathway analysis
was carried out using Ingenuity software and targetswere predicted based on
targetscan.org (TargetScanHuman version 5.1) (20).
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